Granite Bio AG
Pharmaceuticals · Basel, Basel-Stadt
Granite Bio AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2021 (UID CHE-465.152.120).
Board members & signatories
- Eliot Forster — Präsident des Verwaltungsrates
- Patrick Loustau — Mitglied des Verwaltungsrates
- Laia Crespo Martin — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien. Die Gesellschaft kann alle kommerziellen, vertraglichen und finanziellen Geschäfte eingehen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit in Zusammenhang stehen. …
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Granite Bio does
OFFERING
Granite Bio AG focuses on the development of therapeutic antibodies targeting inflammation, autoimmunity, and fibrosis. Their pipeline includes two first-in-class assets: Minokitug, which depletes pro-inflammatory monocytes and is currently in Phase 1b testing for inflammatory bowel disease, and GRT-002, which blocks interleukin-3 and is in preclinical development.
Unlock the full analysis →Similar companies
- Bright Peak Therapeutics AG — Pharmaceuticals · Allschwil
- Red Ridge Bio AG — Pharmaceuticals · Basel
- argenx Switzerland SA — Pharmaceuticals · Châtelaine
- Adagene AG — Pharmaceuticals · Basel
- T3 Pharmaceuticals AG — Pharmaceuticals · Allschwil
- Biogen International GmbH — Biotechnology · Baar
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime